Investing.com - DocGo (NASDAQ: DCGO) reported first quarter EPS of $-0.030, $0.05 worse than the analyst estimate of $0.020. Revenue for the quarter came in at $113M versus the consensus estimate of $112.07M.
Guidance
DocGo sees FY 2023 revenue of $500.000M-$510.000M versus the analyst consensus of $504.000M.
DocGo's stock price closed at $8.430. It is down -9.350% in the last 3 months and up 32.340% in the last 12 months.
DocGo saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See DocGo's stock price’s past reactions to earnings here.
According to InvestingPro, DocGo's Financial Health score is "great performance".
Check out DocGo's recent earnings performance, and DocGo's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar